SCHEMBL7519640

SCHEMBL7519640

CC(C)n1c(=O)[nH]cc(Cc2ccccc2)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ADORA2A P29274 2/20 0.41
ADORA1 P30542 2/20 0.41
FEN1 P39748 3/20 0.39
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PNP P00491 1/20 0.38
BRD4 O60885 1/20 0.38
DAO P14920 2/20 0.38
ERCC5 P28715 1/20 0.37
POLB P06746 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MET P08581 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7512202 0.88 ALDH1A1 (0.44) MEN1KMT2AADORA2AADORA1PDE3B
SCHEMBL20577735 0.75 CASP3 (0.41) MEN1KMT2ABRD4
SCHEMBL18835018 0.68 GFER (0.45) MEN1KMT2AADORA2AADORA1FEN1
SCHEMBL23163270 0.68 SLC9A1 (0.38) POLBL3MBTL1
SCHEMBL5223001 0.67 KMT2A (0.62) MEN1KMT2AADORA2AADORA1PNP
SCHEMBL13244912 0.67 PDE5A (0.49) MEN1KMT2AADORA2AADORA1PDE3B
SCHEMBL12794269 0.67 PDE3B (0.42) KMT2APDE3BPDE3AL3MBTL1CYP1A2
SCHEMBL22471432 0.66 PGR (0.36) SMN1; SMN2POLBL3MBTL1
SCHEMBL24450051 0.66 GAA (0.35) MEN1KMT2ADAOPOLBL3MBTL1
SCHEMBL19335113 0.66 HSD17B10 (0.46) MEN1KMT2ASMN1; SMN2DAOPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107778254-A The synthetic method of the pyrimidine derivatives of Internmediate of anti viral medicine oxo two 陈国妃 2018-03-09 CN disclosed
CN-1352637-A Process for preparing MKC-442 TRIANGLE PHARMACEUTICALS INC (US) 2002-06-05 CN disclosed
EP-1169310-A1 PROCESS FOR PREPARING MKC-442 Triangle Pharmaceuticals Inc. (US) 2002-01-09 EP disclosed
EP-1169310-A1 PROCESS FOR PREPARING MKC-442 Triangle Pharmaceuticals Inc. (US) 2002-01-09 EP disclosed
WO-2000061566-A1 PROCESS FOR PREPARING MKC-442 TRIANGLE PHARMACEUTICALS, INC. (US) 2000-10-19 WO disclosed
WO-2000061566-A1 PROCESS FOR PREPARING MKC-442 TRIANGLE PHARMACEUTICALS, INC. (US) 2000-10-19 WO disclosed